Our specialist fields
Our striving for the best possible solution – verifiable healing, protection or improved quality of life – determines our entrepreneurial actions. We take care of all aspects that serve the health and well-being of patients and particularly focus on our specialist fields in which we have many years of experience and the highest level of professional competence.
The correct diagnosis and multimodal therapy of attention deficit hyperactivity disorder (ADHD) benefits from a wide range of treatment options. Here we are the Number One in the treatment of children and adolescents, but also adults, in terms of prescriptions in Germany and Europe (source: iqvia 2020, insight 2020 reports): with Medikinet® and Medikinet® retard (methylphenidate 8 hours of efficacy), with Attentin® (the first and only dexamfetamine finished medicinal product), with Kinecteen® (a fast-acting, 12-hour methylphenidate), with Medikinet® adult (the first medication approved in Germany to treat adult ADHD patients), and most recently with Agakalin® and Audalis® (atomoxetine, a non-stimulant in tablet form).
For many years now, MEDICE has been a leading player in the German self-medication market. The efficacy of our products is scientifically proven and their quality is convincing. In pharmacies, our top brands for self-medication, such as Meditonsin®, Soventol®, Perenterol® or Dorithricin®, prove their merit every day. Because they are convincing with their quality and are of proven efficacy. Efficacy and benefit are also the hallmarks of our prescription drugs – medically sound and health-enhancing. While Circadin®, the first melatonin drug approved for the German market, promotes healthy sleep, Medivitan® has long been the established market leader among parenteral vitamin B fortifying treatments.
Nephrology is an important focus of our research-oriented development work. As experts in kidney diseases and in their causes and consequences, we are a recognized partner of medical specialists and dialysis centres alike. Our products and services are precisely tailored to the individual challenges of this indication area – and our comprehensive range of drugs makes it possible to slow the progression of disease and treat nephrological complications.
Our subsidiary Friend-Ship develops innovative and pioneering ecological sustainability projects with an emphasis on food waste management. Eric Neyret is responsible for the management of Friend-Ship GmbH.
MediVentures GmbH, is a venture capital firm based in Munich. The business model stands on three pillars – investing, consulting and networking. MediVentures searches for innovative projects and business models and promotes their development with financial resources, by accompanying them in early development phases and by providing access to a broad network in the healthcare industry.